Health CanadaGeneral Alert
Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Sa...
Published: February 11, 2005Recall ID: 24396Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information
Product Description & Identification
Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24396 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-has-suspended-market-authorization-adderall-xrtm-amphetamine-salts-drug |
| Issue | New safety information |
| Title | Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in Children |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2005-02-11 |
| Organization | Marketed health products |